The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD

Claessens, Y.-É., Park, S., Dubart‐Kupperschmitt, A., Mariot, V., Garrido, C., Chrétien, S., Dreyfus, F., Lacombe, C., Mayeux, P., & Fontenay, M. (2005) · Blood · doi:10.1182/blood-2004-08-3166 · Cited by 66

CD95 triggers Orai1-mediated localized Ca 2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation

Khadra, N., Bresson‐Bepoldin, L., Penna, A., Chaigne-Delalande, B., Ségui, B., Levade, T., Vacher, A.-M., Reiffers, J. J., Ducret, T., Moreau, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116946108 · Cited by 65

OX40/OX40L Costimulation Affects Induction of Foxp3+ Regulatory T Cells in Part by Expanding Memory T Cells In Vivo

Xiao, X., Kroemer, A., Gao, W., Ishii, N., Demirci, G., & Li, X. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3193 · Cited by 63

TNF inhibitors – Mechanisms of action, approved and off-label indications

Cessak, G., Kuzawińska, O., Burda, A., Lis, K., Wojnar, M., Mirowska-Guzel, D. M., & Bałkowiec-Iskra, E. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.05.004 · Cited by 63

Impaired c-Jun Amino Terminal Kinase Activity and T Cell Differentiation in Death Receptor 6–deficient Mice

Zhao, H., Yan, M., Wang, H., Erickson, S. L., Grewal, I. S., & Dixit, V. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1441 · Cited by 63

Properties of murine CD8+CD27- T cells

Baars, P. A., Sierro, S. R., Arens, R., Tesselaar, K., Hooibrink, B., Klenerman, P., & van Lier, R. A. W. (2005) · European Journal of Immunology · doi:10.1002/eji.200425770 · Cited by 63

CD95-mediated cell signaling in cancer: mutations and post-translational modulations

Tauzin, S., Debure, L., Moreau, J., & Legembre, P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0866-4 · Cited by 61

Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis

Muppidi, J. R., Lobito, A. A., Ramaswamy, M., Yang, J. K., Wang, L., Wu, H., & Siegel, R. M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401855 · Cited by 60

Biphasic role of 4‐1BB in the regulation of mouse cytomegalovirus‐specific CD8+ T cells

Humphreys, I. R., Lee, S., Jones, M., Loewendorf, A. I., Emma Gostick, D., Price, D. A., Benedict, C. A., Ware, C. F., & Croft, M. (2010) · European Journal of Immunology · doi:10.1002/eji.200940256 · Cited by 60

Tumor Necrosis Factor Receptor Superfamily Member 21: TNFR-Related Death Receptor-6, DR6

Benschop, R. J., Wei, T., & Na, S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_13 · Cited by 59

Solution NMR Investigation of the CD95/FADD Homotypic Death Domain Complex Suggests Lack of Engagement of the CD95 C Terminus

Esposito, D., Sankar, A., Morgner, N., Robinson, C. V., Rittinger, K., & Driscoll, P. C. (2010) · Structure · doi:10.1016/j.str.2010.08.006 · Cited by 59

Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice

Gaspal, F., Withers, D. R., Saini, M., Bekiaris, V., McConnell, F. M., White, A. J., Khan, M., Yagita∥, H., Walker, L. S. K., Anderson, G., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101484 · Cited by 59

Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease

Lobito, A. A., Gabriel, T. L., Medema, J. P., & Kimberley, F. C. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.006 · Cited by 59

OX40 and CD30 signals in CD4+ T‐cell effector and memory function: a distinct role for lymphoid tissue inducer cells in maintaining CD4+ T‐cell memory but not effector function

Withers, D. R., Gaspal, F., Bekiaris, V., McConnell, F. M., Kim, M., Anderson, G., & Lane, P. J. L. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01057.x · Cited by 58

The death receptor CD95 activates the cofilin pathway to stimulate tumour cell invasion

Steller, E. J. A., Ritsma, L., Raats, D., Hoogwater, F. J. H., Emmink, B. L., Govaert, K. M., Laoukili, J., Rinkes, I. H. M. B., van Rheenen, J., & Kranenburg, O. (2011) · EMBO Reports · doi:10.1038/embor.2011.129 · Cited by 58

The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4 + and CD8 + T‐cell immunity

Twohig, J. P., Marsden, M., Cuff, S. M., Ferdinand, J. R., Gallimore, A., Perks, W. V., Al‐Shamkhani, A., Humphreys, I. R., & Wang, E. C. Y. (2012) · The FASEB Journal · doi:10.1096/fj.11-200618 · Cited by 57

Human and Mouse Colon Cancer Utilizes CD95 Signaling for Local Growth and Metastatic Spread to Liver

Li, H., Fan, X., Stoicov, C., Liu, J. H., Zubair, S., Tsai, E., Marie, R. S., Wang, T. C., Lyle, S. R., Kurt‐Jones, E. A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.004 · Cited by 57

CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells

Drachsler, M. W., Kleber, S., Mateos, Á., Volk, K., Mohr, N., Chen, S., Cirovic, B., Tüttenberg, J., Gieffers, C., Sýkora, J., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.102 · Cited by 57

OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses

Ishii, N., Ndhlovu, L. C., Murata, K., Sato, T., Kamanaka, M., & Sugamura, K. (2003) · European Journal of Immunology · doi:10.1002/eji.200324031 · Cited by 56

Differential Impact of CD27 and 4-1BB Costimulation on Effector and Memory CD8 T Cell Generation following Peptide Immunization

Willoughby, J. E., Kerr, J. P., Rogel, A., Taraban, V. Y., Buchan, S. L., Johnson, P., & Al‐Shamkhani, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301217 · Cited by 55

CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma

Teodorczyk, M., Kleber, S., Wollny, D., Sefrin, J. P., Aykut, B., Mateos, Á., Herhaus, P., Sancho-Martinez, I., Hill, O., Gieffers, C., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.217 · Cited by 55

Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response

Talotta, R., Berzi, A., Atzeni, F., Batticciotto, A., Clerici, M., Sarzi‐Puttini, P., & Trabattoni, D. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0182-0 · Cited by 54

Treating multiple sclerosis with monoclonal antibodies: a 2013 update

Deiß, A., Brecht, I., Haarmann, A., & Buttmann, M. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.17 · Cited by 53

Activation of OX40 Augments Th17 Cytokine Expression and Antigen-Specific Uveitis

Zhang, Z., Zhong, W., Hinrichs, D. J., Wu, X., Weinberg, A. D., Hall, M., Spencer, D., Wegmann, K. W., & Rosenbaum, J. T. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100353 · Cited by 51

Enhanced B Cell Expansion, Survival, and Humoral Responses by Targeting Death Receptor 6

Schmidt, C. S., Liu, J., Zhang, T., Song, H. Y., Sandusky, G. E., Mintze, K., Benschop, R. J., Glasebrook, A. L., Yang, D. D., & Na, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020617 · Cited by 51

CD30: from basic research to cancer therapy

Muta, H., & Podack, E. R. (2013) · Immunologic Research · doi:10.1007/s12026-013-8464-1 · Cited by 50

The TWEAK/Fn14 Pathway in Tissue Remodeling: For Better or for Worse

Burkly, L. C., & Dohi, T. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6612-4_32 · Cited by 49

Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)

Torre, F. L., Muratore, M., Vitale, A., Moramarco, F., Quarta, L., & Cantarini, L. (2015) · Rheumatology International · doi:10.1007/s00296-015-3305-2 · Cited by 49

Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X‐linked ectodermal dysplasia

Mauldin, E. A., Gaide, O., Schneider, P., & Casal, M. L. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32916 · Cited by 49

Toward understanding ubiquitin-modifying enzymes: from pharmacological targeting to proteomics

Lill, J. R., & Wertz, I. E. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.01.005 · Cited by 49

CD4+ T helper cells use CD154–CD40 interactions to counteract T reg cell–mediated suppression of CD8+ T cell responses to influenza

Ballesteros‐Tato, A., León, B., Lund, F. E., & Randall, T. D. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130097 · Cited by 49

Role of the TWEAK/Fn14 pathway in autoimmune diseases

Xu, W., Zhao, Y., & Liu, Y. (2015) · Immunologic Research · doi:10.1007/s12026-015-8761-y · Cited by 49

Precambrian origins of the TNFR superfamily

Quistad, S. D., & Traylor‐Knowles, N. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.58 · Cited by 49

The Lymphotoxin LTα1β2 Controls Postnatal and Adult Spleen Marginal Sinus Vascular Structure and Function

Zindl, C. L., Kim, T. H., Zeng, M., Archambault, A. S., Grayson, M. H., Choi, K., Schreiber, R. D., & Chaplin, D. (2009) · Immunity · doi:10.1016/j.immuni.2009.01.010 · Cited by 48

Tumor Necrosis Factor Receptor 2 (TNFR2) Signaling Is Negatively Regulated by a Novel, Carboxyl-terminal TNFR-associated Factor 2 (TRAF2)-binding Site

Grech, A. P., Gardam, S., Chan, T. D., Quinn, R., Gonzales, R., Basten, A., & Brink, R. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504849200 · Cited by 48

Ectodysplasin research—Where to next?

Lefebvre, S., & Mikkola, M. L. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.05.002 · Cited by 44

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

Cencioni, M. T., Santini, S., Ruocco, G., Borsellino, G., Bardi, M. D., Grasso, M. G., Ruggieri, S., Gasperini, C., Centonze, D., Barilà, D., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.100 · Cited by 43

Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis

Huang, G., Lee, X., Bian, Y., Shao, Z., Sheng, G.-N., Pepinsky, R. B., & Mi, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.378 · Cited by 43

GITR signaling potentiates airway hyperresponsiveness by enhancing Th2 cell activity in a mouse model of asthma

Motta, A. C., Vissers, J. L. M., Gras, R., van Esch, B. C. A. M., van Oosterhout, A. J. M., & Nawijn, M. C. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-93 · Cited by 43

Caspase-8- and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production

Matsumoto, N., Ryu, I., & Suda, T. (2007) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 42

Prevention of Autoimmunity and Control of Recall Response to Exogenous Antigen by Fas Death Receptor Ligand Expression on T Cells

Mabrouk, I., Buart, S., Hasmim, M., Michiels, C., Connault, E., Opolon, P., Chiocchia, G., Lévi‐Strauss, M., Chouaı̈b, S., & Karray, S. (2008) · Immunity · doi:10.1016/j.immuni.2008.10.007 · Cited by 39

Roles of ligands from the TNF superfamily in B cell development, function, and regulation

Figgett, W. A., Vincent, F. B., Saulep-Easton, D., & Mackay, F. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.06.001 · Cited by 38

Pharmacokinetics, pharmacodynamics, safety and tolerability of APG101, a CD95-Fc fusion protein, in healthy volunteers and two glioma patients

Tuettenberg, J., Seiz, M., Debatin, K., Hollburg, W., von Staden, M., Thiemann, M., Hareng, B., Fricke, H., & Kunz, C. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.03.004 · Cited by 38

CD27 cooperates with the pre-T cell receptor in the regulation of murine T cell development.

Gravestein, L. A., van Ewijk, W., OSSENDORP, F. A., & Borst, J. G. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.675 · Cited by 38

CD40 on APCs Is Needed for Optimal Programming, Maintenance, and Recall of CD8+ T Cell Memory Even in the Absence of CD4+ T Cell Help

Hernandez, M. G. H., Shen, L., & Rock, K. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4382 · Cited by 35

TNF-like Ligand 1A (TL1A) Gene Knockout Leads to Ameliorated Collagen-Induced Arthritis in Mice: Implication of TL1A in Humoral Immune Responses

Wang, X., Hu, Y., Charpentier, T., Lamarre, A., Qi, S., Wu, J., & Luo, H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301475 · Cited by 35

Mature B Cells Are Critical to T-cell-mediated Tumor Immunity Induced by an Agonist Anti-GITR Monoclonal Antibody

Zhou, P., Qiu, J., L’Italien, L., Gu, D., Hodges, D., Chao, C., & Schebye, X. M. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181ee6ba9 · Cited by 35

Targeting the Fas/FasL system in Rheumatoid Arthritis therapy: Promising or risky?

Calmon-Hamaty, F., Audo, R., Combe, B. G., Morel, J., & Hahne, M. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.004 · Cited by 33

LTβR signaling in dendritic cells induces a type I IFN response that is required for optimal clonal expansion of CD8 + T cells

deLuca, L. S., Ng, D., Gao, Y., Wortzman, M. E., Watts, T. H., & Gommerman, J. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014188108 · Cited by 33

Oligomerized tumor necrosis factor‐related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways

Berg, D., Stühmer, T., Siegmund, D., et al. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07388.x · Cited by 32

Enhanced CD8 T Cell Responses through GITR-Mediated Costimulation Resolve Chronic Viral Infection

Pascutti, M. F., Geerman, S., Slot, E. M., van Gisbergen, K. P. J. M., Boon, L., Arens, R., van Lier, R. A. W., Wolkers, M. C., & Nolte, M. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004675 · Cited by 32

Anti-GITR Agonist Therapy Intrinsically Enhances CD8 T Cell Responses to Chronic Lymphocytic Choriomeningitis Virus (LCMV), Thereby Circumventing LCMV-Induced Downregulation of Costimulatory GITR Ligand on APC

Clouthier, D., Zhou, A. C., & Watts, T. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401002 · Cited by 31

Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease

Brost, S., Koschny, R., Sykora, J., Stremmel, W., Lasitschka, F., Walczak, H., & Ganten, T. M. (2009) · Pathology - Research and Practice · doi:10.1016/j.prp.2009.09.005 · Cited by 31

Impaired B Cell Receptor Signaling Is Responsible for Reduced TACI Expression and Function in X-Linked Immunodeficient Mice

Uslu, K., Coleman, A. S., Allman, W. R., Katsenelson, N., Bram, R. J., Alugupalli, K. R., & Akkoyunlu, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1203468 · Cited by 30

Endothelial cell-derived CD95 ligand serves as a chemokine in induction of neutrophil slow rolling and adhesion

Gao, L., Balta, G. S. G., Golbach, L. A., Block, H., Zarbock, A., & Martín-Villalba, A. (2016) · eLife · doi:10.7554/elife.18542 · Cited by 30

Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis

Kim, E. Y., Chi, H. H., Rajaiah, R., & Moudgil, K. D. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2393 · Cited by 29

Dendritic Cells and Stat3 Are Essential for CD137-Induced CD8 T Cell Activation-Induced Cell Death

Zhang, B., Zhang, Y., Niu, L., Vella, A. T., & Mittler, R. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902713 · Cited by 28

The crystal structure of DR6 in complex with the amyloid precursor protein provides insight into death receptor activationPreprint

Xu, K. Y., Olsen, O., Tzvetkova‐Robev, D., Tessier‐Lavigne, M., & Nikolov, D. B. (2015) · Genes & Development · doi:10.1101/gad.257675.114 · Cited by 28

CD8+T Cells: GITR Matters

Ronchetti, S., Nocentini, G., Petrillo, M. G., & Riccardi, C. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/308265 · Cited by 28

Death receptor 6 contributes to autoimmunity in lupus-prone mice

Fujikura, D., Ikesue, M., Endo, T., Chiba, S., Higashi, H., & Uede, T. (2017) · Nature Communications · doi:10.1038/ncomms13957 · Cited by 27

Basophil-associated OX40 Ligand Participates in the Initiation of Th2 Responses during Airway Inflammation

Di, C., Lin, X., Zhang, Y., Zhong, W., Yuan, Y., Zhou, T., Liu, J., & Xia, Z. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.642637 · Cited by 25

Resistance to Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis by Death Receptor 6-Deficient Mice

Schmidt, C. S., Zhao, J., Chain, J. S., Hepburn, D. L., Gitter, B. D., Sandusky, G. E., Chintalacharuvu, S. R., Glasebrook, A. L., & Na, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2286 · Cited by 24

Chronic CD70-Driven Costimulation Impairs IgG Responses by Instructing T Cells to Inhibit Germinal Center B Cell Formation through FasL-Fas Interactions

Beishuizen, C. R. L., Kragten, N. A. M., Boon, L., Nolte, M. A., van Lier, R. A. W., & van Gisbergen, K. P. J. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901565 · Cited by 21

Increasing the Survival of Dendritic Cells In Vivo Does Not Replace the Requirement for CD4+ T Cell Help during Primary CD8+ T Cell Responses

Matthews, K. E., Qin, J., Yang, J., Hermans, I. F., Palmowski, M. J., Cerundolo, V., & Ronchese, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5738 · Cited by 16

ARG098, a novel anti-human Fas antibody, suppresses synovial hyperplasia and prevents cartilage destruction in a severe combined immunodeficient-HuRAg mouse model

Odani‐Kawabata, N., Takai-Imamura, M., Katsuta, O., Nakamura, H., Nishioka, K., Funahashi, K., Matsubara, T., Sasano, M., & Aono, H. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-221 · Cited by 16

Regulation of cell fate by lymphotoxin (LT) receptor signalling: Functional differences and similarities of the LT system to other TNF superfamily (TNFSF) members

Albarbar, B., Dunnill, C., & Georgopoulos, N. T. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.05.001 · Cited by 15

Erratum: FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

Cencioni, M. T., Santini, S., Ruocco, G., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.164 · Cited by 15

APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis

Raimbault, A., Myélodysplasies, O. B. O. T. G. F. D., Pierre‐Eugène, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7469 · Cited by 11

Requirement of CD30 expression on CD4 T cells in the pathogenesis of experimental autoimmune encephalomyelitis

Shinoda, K., Sun, X., Oyamada, A., Yamada, H., Kira, J., & Yoshikai, Y. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.12.005 · Cited by 10

Atlas of the plasma proteome in health and disease in 53,026 adults

Deng, Y.-T., You, J., He, Y., Zhang, Y., Li, H.-Y., Wu, X.-R., Cheng, J.-Y., Guo, Y., Long, Z.-W., Chen, Y.-L., et al. (2025) · Cell · doi:10.1016/j.cell.2024.10.045 · Cited by 294

Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects

Gough, P., & Myles, I. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585880 · Cited by 268

Cytokine and Chemokine Signals of T‐Cell Exclusion in Tumors

Zhang, Y., Guan, X.-Y., & Jiang, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594609 · Cited by 133

Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms

Fisher, D. A. C., Fowles, J. S., Zhou, A., & Oh, S. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683401 · Cited by 115

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury

Krishnan, A., Ozturk, N. B., Cutshaw, K. A., Guicciardi, M. E., Kitagataya, T., Olson, K. E., Pavelko, K. D., Sherman, W., Wixom, A. Q., Jalan-Sakrikar, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52710-3 · Cited by 8